Samalin Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Sell |
3,326
-255
| -7% | -$47.3K | 0.24% | 123 |
|
|
2025
Q1 | $750K | Buy |
3,581
+288
| +9% | +$60.4K | 0.3% | 98 |
|
|
2024
Q4 | $585K | Buy |
3,293
+5
| +0.2% | +$889 | 0.25% | 114 |
|
|
2024
Q3 | $649K | Sell |
3,288
-2,063
| -39% | -$407K | 0.28% | 107 |
|
|
2024
Q2 | $918K | Sell |
5,351
-17
| -0.3% | -$2.92K | 0.43% | 57 |
|
|
2024
Q1 | $978K | Sell |
5,368
-61
| -1% | -$11.1K | 0.47% | 59 |
|
|
2023
Q4 | $841K | Sell |
5,429
-17
| -0.3% | -$2.64K | 0.43% | 64 |
|
|
2023
Q3 | $812K | Sell |
5,446
-53
| -1% | -$7.9K | 0.47% | 59 |
|
|
2023
Q2 | $741K | Sell |
5,499
-307
| -5% | -$41.4K | 0.4% | 69 |
|
|
2023
Q1 | $925K | Sell |
5,806
-15
| -0.3% | -$2.39K | 0.56% | 50 |
|
|
2022
Q4 | $941K | Buy |
5,821
+19
| +0.3% | +$3.07K | 0.59% | 46 |
|
|
2022
Q3 | $779K | Sell |
5,802
-111
| -2% | -$14.9K | 0.57% | 50 |
|
|
2022
Q2 | $906K | Sell |
5,913
-3,212
| -35% | -$492K | 0.64% | 46 |
|
|
2022
Q1 | $1.48M | Sell |
9,125
-28
| -0.3% | -$4.54K | 0.9% | 25 |
|
|
2021
Q4 | $1.24M | Sell |
9,153
-1,345
| -13% | -$182K | 0.74% | 30 |
|
|
2021
Q3 | $1.13M | Buy |
10,498
+175
| +2% | +$18.9K | 0.74% | 29 |
|
|
2021
Q2 | $1.16M | Buy |
10,323
+88
| +0.9% | +$9.91K | 0.75% | 26 |
|
|
2021
Q1 | $1.11M | Buy |
10,235
+341
| +3% | +$36.9K | 0.74% | 29 |
|
|
2020
Q4 | $1.06M | Sell |
9,894
-327
| -3% | -$35K | 0.8% | 27 |
|
|
2020
Q3 | $895K | Buy |
10,221
+7,465
| +271% | +$654K | 0.8% | 30 |
|
|
2020
Q2 | $270K | Sell |
2,756
-171
| -6% | -$16.8K | 0.28% | 116 |
|
|
2020
Q1 | $223K | Sell |
2,927
-145
| -5% | -$11K | 0.3% | 103 |
|
|
2019
Q4 | $272K | Buy |
+3,072
| New | +$272K | 0.23% | 119 |
|